Management Reports on BioPortfolio by title 301-400

• Management Reports on BioPortfolio by title 1-100
• Management Reports on BioPortfolio by title 101-200
• Management Reports on BioPortfolio by title 201-300
• Management Reports on BioPortfolio by title 301-400
• Management Reports on BioPortfolio by title 401-500
• Management Reports on BioPortfolio by title 501-600

If the link is not shown please go to the following page and use the search function:

http://www.bioportfolio.com/cgi-bin/acatalog/search.html

Click title to view report description:

Japanese Pharma to 2008: Innovation and Expansion Will Counter the Western Threat
Commercial Insight: Asthma and COPD - Combinations breathe life into the asthma and COPD markets
Stakeholder Perspectives: Asthma - Improvements to Combination Inhalers Will Satisfy a Growing Patient Base
Cystic Fibrosis - Countdown to a Cure?
Community Acquired Respiratory Tract Infections - Room for Ketek?
Respiratory Syncytial Virus: Can Antivirals Make the Grade?
Stakeholder Insight: Osteoporosis - Poor Disease Awareness and Patient Identification Hinder Market Growth
Hormonal Contraception: Market Update - Surviving the Generic Threat
Urinary Incontinence: Market Update - Growing Market Brings Opportunities for New Drugs
Commercial Insight: Osteoporosis & HRT - HRT is down for the count, but can osteoporosis players pick up the pieces?
Pipeline Insight: Hormone Replacement Therapy - Wyeth positions to strike back?
Osteoporosis - Intermittent Dosing and Multiple Indications Drive Market Growth
Strategic Perspectives: Hormone Replacement Therapy - Women’s Health Initiative Drives Long-term Shift Towards Short-term Treatment.
Cell-Based Assays
Post-Genomic Biomarkers
Protein Arrays
Cell Therapy
Antibody Market Update
Nuclear Receptors
Functional Genomics Turning Promise into Profits
Molecular Diagnostics
Commercial Opportunities in RNA Interference
Chiral Technologies
The Bioprocessing Industry Increasing Capacity, Production, and Efficiency
Lead Optimization
Biochip Technologies Seizing New Opportunities in a Complex Market
Ion Channels
High Density Multiplexed Assays
Pharmaceutical Packaging Trends Driving Innovation and Market Opportunities
Cytokines, Chemokines, and Growth Factors
Microbiotechnology Seizing New Opportunities in a Complex Market
Microfluidics
Protein Kinases
Managing Toxicology for the Future
Drug Discovery Technologies & Strategies III
Cell Signalling Pathways
Peptide Therapeutics: Applications in the Treatment of Human Diseases
Transdermal and Transmucosal Therapeutics
Phosphatases Emerging Role in Signal Transduction, Human Therapeutics, As Drug Targets
Systems Biology: Key to Unlocking the Value within the Omics Revolution
Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics
A Guide to Green-Fluorescent Protein
A Guide to Competitive Intelligence for the Life Sciences Industry
A Guide to Assay Development
A Guide to Due Diligence in Life Science Transactions
A Guide to Successful SBIR STTR Grant Writing
A Guide to Achieving Reimbursement for Medical Devices, Diagnostics, and Pharmaceuticals
A Guide to Good Manufacturing Practice
A Guide to European Union Pharmaceutical Regulations
A Guide to Evaluating and Choosing CROs
A Guide to Good Validation Practice
A Guide to Successful Technology Licensing
A Guide to Viral Clearance

PharmaVitae 2003: Merck & Co.
PharmaVitae 2003: Biogen
PharmaVitae 2003: Shionogi
PharmaVitae 2003: Forest
PharmaVitae 2003: Amgen
PharmaVitae 2003: Akzo Nobel
PharmaVitae 2003: Shire
PharmaVitae 2003: Pfizer
PharmaVitae 2003: AstraZeneca
PharmaVitae 2003: Bristol-Myers Squibb
PharmaVitae 2003: Schering AG
PharmaVitae 2003: GlaxoSmithKline
PharmaVitae 2003: Roche
PharmaVitae 2003: Serono
PharmaVitae 2003: Lundbeck
PharmaVitae 2003: Schering-Plough
PharmaVitae 2003: Wyeth
PharmaVitae 2003: Genentech
PharmaVitae 2003: Eli Lilly
PharmaVitae 2003: Aventis
PharmaVitae 2003: Biogen-IDEC
PharmaVitae 2003: Novartis
PharmaVitae 2003: Solvay
PharmaVitae 2003: Bayer
PharmaVitae 2003: Yamanouchi
PharmaVitae 2003: Abbott
PharmaVitae 2003: Eisai
PharmaVitae 2003: Sankyo
PharmaVitae 2003: Chiron
PharmaVitae 2003: Takeda
PharmaVitae 2003: Gilead
PharmaVitae 2003: Celltech
PharmaVitae 2003: Boehringer Ingelheim
PharmaVitae 2003: Johnson & Johnson
PharmaVitae 2003: Genzyme
PharmaVitae 2003: Sanofi-Synthelabo
PharmaVitae 2003: MedImmune
PharmaVitae 2004: King Pharmaceuticals Global Analysis
PharmaVitae 2004: Millennium Global & US Analysis
PharmaVitae 2004: Merck & Co. Global & US Analysis
PharmaVitae 2004: UCB Global Analysis
PharmaVitae 2004: UCB Global & US Analysis
PharmaVitae 2004: Novo Nordisk Global & US Analysis
PharmaVitae 2004: Merck & Co. Global Analysis
PharmaVitae 2004: King Pharmaceuticals Global & US Analysis
PharmaVitae 2004: Novo Nordisk Global Analysis
PharmaVitae 2004: Millennium Global Analysis

Complete list of publishers:

BioPortfolio are seeking new titles and are open to suggestions from our Readers. If you would like BioPortfolio to publish a biotechnology related report please Email our Publications Department.